PHOENIX, Oct. 29, 2014 /PRNewswire/ -- CSL Behring
announced that William McCarthy from
the Western Pennsylvania Chapter of the National Hemophilia
Foundation and Nicholas Cleghorn
from the Bleeding Disorders Advocacy Network are the national
winners of the 2014 Gettin' in the Game(SM) Junior National
Championship (JNC) program in golf and baseball,
respectively. The JNC, launched in 2002, is CSL Behring's
annual baseball and golf competition that encourages kids to remain
active despite the challenges a bleeding disorder can pose, while
allowing them to develop life-long connections with other members
of the community.
"CSL Behring has a long history of providing medical innovations
and supportive services, like the JNC and My Source, that
make a meaningful difference in the lives of those with a bleeding
disorder and those who care for them," said Bill Campbell, Senior Vice President, North
America Commercial Operations, CSL Behring. "We congratulate
William and Nicholas and all of the competitors on their tremendous
accomplishments during the event and throughout the year. CSL
Behring's commitment to the community is long-standing and the JNC
demonstrates our team's passion for what they do."
CSL Behring's JNC program is the first and only national golf
and baseball competition designed specifically for the bleeding
disorders community. In addition to the competitive
activities, this event provides children and their caregivers with
educational information and opportunities to interact with others
in the community.
"CSL Behring understands that it can be helpful for members of
the bleeding disorders community to interact with others who face
similar challenges," said Kim
Phelan, Vice President, The Coalition for Hemophilia B. "CSL
Behring's programs, like the JNC, allow our members to make
connections with those who share similar experiences, and we
greatly appreciate these opportunities."
In addition to naming national golf and baseball champions, CSL
Behring recognized Chase Tulledge
from Hemophilia of Indiana as the
event's national raffle winner. For more information about the JNC
program or the wide variety of resources for the bleeding disorders
community offered by CSL Behring, please visit www.MySourceCSL.com
or call 1-800-676-4266. CSL Behring's My Source program
provides one-stop access to educational information, financial
support and community connections to individuals living with
hemophilia and/or VWD.
About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics
industry. Committed to saving lives and improving the quality of
life for people with rare and serious diseases, the company
manufactures and markets a range of plasma-derived and recombinant
therapies worldwide.
CSL Behring therapies are used around the world to treat
coagulation disorders including hemophilia and von Willebrand
disease, primary immune deficiencies, hereditary angioedema and
inherited respiratory disease, and neurological disorders in
certain markets. The company's products are also used in cardiac
surgery, organ transplantation, burn treatment and to prevent
hemolytic diseases in the newborn.
CSL Behring operates one of the world's largest plasma
collection networks, CSL Plasma. CSL Behring is a global
biopharmaceutical company and a member of the CSL Group of
companies. The parent company, CSL Limited (ASX:CSL), is
headquartered in Melbourne,
Australia. For more information, visit
http://www.cslbehring.com/.
Contact:
Greg Healy
CSL Behring
O: 610-878-4841
Greg. Healy@cslbehring.com
Photo - http://photos.prnewswire.com/prnh/20141028/155031
SOURCE CSL Behring